Thompson S G, Martin J C, Meade T W
MRC Epidemiology, Northwick Park Hospital, Harrow, Middlesex, UK.
Thromb Haemost. 1987 Dec 18;58(4):1073-7.
Estimates of the components of variation of a number of coagulation factor assays are presented and are compared with those for other haematological and biochemical variables. They have been derived from a study in which fourteen volunteers gave blood samples approximately bi-monthly for three years. The systematic between-batch variation was generally only a small component of the total variation. However, the proportion of the total variation due to differences between people ranged from about 15% in the case of two measures of antithrombin III to about 85% for cholesterol and haemoglobin. For factor VII activity and fibrinogen, the figure was just over 70%. These estimates of the components of variation are not generally available in the literature. In view of the increasing interest in the role of coagulation factors in the pathogenesis of arterial disease, estimates of this kind are needed both for the interpretation of observed relationships as well as for planning sample sizes for future studies.
本文给出了多项凝血因子检测变异成分的估计值,并与其他血液学和生化变量的估计值进行了比较。这些估计值来自一项研究,在该研究中,14名志愿者在三年时间里大约每两个月提供一次血样。批次间的系统变异通常只是总变异的一小部分。然而,个体差异导致的总变异比例在抗凝血酶III的两种检测中约为15%,在胆固醇和血红蛋白检测中约为85%。对于因子VII活性和纤维蛋白原,这一数字略高于70%。这些变异成分的估计值在文献中通常无法获得。鉴于对凝血因子在动脉疾病发病机制中作用的兴趣日益增加,这类估计值对于解释观察到的关系以及规划未来研究的样本量都是必要的。